Author: Knight, H.; Jia, R.; Ayling, K.; Bradbury, K.; Baker, K.; Chalder, T.; Morling, J. R.; Durrant, L.; Avery, T.; Ball, J.; Barker, C.; Bennett, R.; McKeever, T.; vedhara, k.
Title: Understanding and Addressing Vaccine Hesitancy in the Context of COVID-19: Development of a Digital intervention Cord-id: oio6y0q1 Document date: 2021_3_26
ID: oio6y0q1
Snippet: Background Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75-90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urge
Document: Background Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75-90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. Method We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. Discussion The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.
Search related documents:
Co phrase search for related documents- abstract screening and longitudinal study: 1
- abstract screening title and acute respiratory: 1, 2, 3, 4
- abstract screening title and longitudinal study: 1
- acceptance hesitancy and acute respiratory: 1, 2, 3
- acceptance vaccine hesitancy and acute respiratory: 1, 2, 3
- accessible equitable and acute respiratory: 1, 2
- acute respiratory and additional concern: 1, 2
- acute respiratory and long term complication: 1, 2, 3, 4, 5, 6, 7
- acute respiratory and long term effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute respiratory and long term protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and long term protection provide: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date